Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
S1PR1 Biologics Sequence Review Report 2026: Sphingosine 1-phosphate receptor 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of S1PR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PDGFD Biologics Sequence Review Report 2026: Platelet-derived growth factor D Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFD protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PDGFC Biologics Sequence Review Report 2026: Platelet-derived growth factor C Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PDGFB Biologics Sequence Review Report 2026: Platelet-derived growth factor subunit B Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PDGFA Biologics Sequence Review Report 2026: Platelet-derived growth factor subunit A Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of PDGFA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
P2RY8 Biologics Sequence Review Report 2026: S-geranylgeranyl-glutathione receptor P2RY8 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of P2RY8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP28 Biologics Sequence Review Report 2026: Matrix metalloproteinase-28 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP28 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP27 Biologics Sequence Review Report 2026: Matrix metalloproteinase-27 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP26 Biologics Sequence Review Report 2026: Matrix metalloproteinase-26 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP25 Biologics Sequence Review Report 2026: Matrix metalloproteinase-25 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP25 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP23B Biologics Sequence Review Report 2026: Matrix metalloproteinase-23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP23B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
MMP21 Biologics Sequence Review Report 2026: Matrix metalloproteinase-21 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of MMP21 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
2
3
4
5
>>
1420
>